Metrics
4 Record Views
- Title
- Targeting CD30 as therapy for Hodgkin’s disease. Phase II results with the monoclonal antibody SGN-30
- Creators
- J. P Leonard - Weill Medcl Coll of Cornell Univ, New York, NY; M.D. Anderson Cancer Ctr, Houston, TX; Sylvester Comprehensive Cancer Ctr, Miami, FL; Univ of Washington, Seattle, WA; Olive View UCLA Medcl Ctr, Sylmar, CA; Siteman Cancer Ctr, St Louis, MO; Univ of Minnesota, Minneapolis, MN; Univ of Alabama-Birmingham, Birmingham, AL; Seattle Genetics, Bothell, WAA Younes - Weill Medcl Coll of Cornell Univ, New York, NY; M.D. Anderson Cancer Ctr, Houston, TX; Sylvester Comprehensive Cancer Ctr, Miami, FL; Univ of Washington, Seattle, WA; Olive View UCLA Medcl Ctr, Sylmar, CA; Siteman Cancer Ctr, St Louis, MO; Univ of Minnesota, Minneapolis, MN; Univ of Alabama-Birmingham, Birmingham, AL; Seattle Genetics, Bothell, WAJ. D Rosenblatt - Weill Medcl Coll of Cornell Univ, New York, NY; M.D. Anderson Cancer Ctr, Houston, TX; Sylvester Comprehensive Cancer Ctr, Miami, FL; Univ of Washington, Seattle, WA; Olive View UCLA Medcl Ctr, Sylmar, CA; Siteman Cancer Ctr, St Louis, MO; Univ of Minnesota, Minneapolis, MN; Univ of Alabama-Birmingham, Birmingham, AL; Seattle Genetics, Bothell, WAA Gopal - Weill Medcl Coll of Cornell Univ, New York, NY; M.D. Anderson Cancer Ctr, Houston, TX; Sylvester Comprehensive Cancer Ctr, Miami, FL; Univ of Washington, Seattle, WA; Olive View UCLA Medcl Ctr, Sylmar, CA; Siteman Cancer Ctr, St Louis, MO; Univ of Minnesota, Minneapolis, MN; Univ of Alabama-Birmingham, Birmingham, AL; Seattle Genetics, Bothell, WAL. C Pinter-Brown - Weill Medcl Coll of Cornell Univ, New York, NY; M.D. Anderson Cancer Ctr, Houston, TX; Sylvester Comprehensive Cancer Ctr, Miami, FL; Univ of Washington, Seattle, WA; Olive View UCLA Medcl Ctr, Sylmar, CA; Siteman Cancer Ctr, St Louis, MO; Univ of Minnesota, Minneapolis, MN; Univ of Alabama-Birmingham, Birmingham, AL; Seattle Genetics, Bothell, WAN. L Bartlett - Weill Medcl Coll of Cornell Univ, New York, NY; M.D. Anderson Cancer Ctr, Houston, TX; Sylvester Comprehensive Cancer Ctr, Miami, FL; Univ of Washington, Seattle, WA; Olive View UCLA Medcl Ctr, Sylmar, CA; Siteman Cancer Ctr, St Louis, MO; Univ of Minnesota, Minneapolis, MN; Univ of Alabama-Birmingham, Birmingham, AL; Seattle Genetics, Bothell, WAL. J Burns - Weill Medcl Coll of Cornell Univ, New York, NY; M.D. Anderson Cancer Ctr, Houston, TX; Sylvester Comprehensive Cancer Ctr, Miami, FL; Univ of Washington, Seattle, WA; Olive View UCLA Medcl Ctr, Sylmar, CA; Siteman Cancer Ctr, St Louis, MO; Univ of Minnesota, Minneapolis, MN; Univ of Alabama-Birmingham, Birmingham, AL; Seattle Genetics, Bothell, WAA Forero - Weill Medcl Coll of Cornell Univ, New York, NY; M.D. Anderson Cancer Ctr, Houston, TX; Sylvester Comprehensive Cancer Ctr, Miami, FL; Univ of Washington, Seattle, WA; Olive View UCLA Medcl Ctr, Sylmar, CA; Siteman Cancer Ctr, St Louis, MO; Univ of Minnesota, Minneapolis, MN; Univ of Alabama-Birmingham, Birmingham, AL; Seattle Genetics, Bothell, WAJ Barton - Weill Medcl Coll of Cornell Univ, New York, NY; M.D. Anderson Cancer Ctr, Houston, TX; Sylvester Comprehensive Cancer Ctr, Miami, FL; Univ of Washington, Seattle, WA; Olive View UCLA Medcl Ctr, Sylmar, CA; Siteman Cancer Ctr, St Louis, MO; Univ of Minnesota, Minneapolis, MN; Univ of Alabama-Birmingham, Birmingham, AL; Seattle Genetics, Bothell, WA
- Publication Details
- Journal of clinical oncology, Vol.23(16_suppl), pp.2553-2553
- Academic Unit
- UMMG Dept of Medicine - Hematology/Oncology; Miller School of Medicine
- Language
- English
- Resource Type
- Journal article
- Record Identifier
- 991031600419302976